Nurix Therapeutics, Inc. (NRIX)
22.16
-0.19
(-0.85%)
USD |
NASDAQ |
Oct 12, 16:00
22.52
+0.36
(+1.62%)
After-Hours: 20:00
Nurix Therapeutics EPS Diluted (Quarterly) : -0.806 for May 31, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | -0.806 |
| February 28, 2026 | -0.792 |
| November 30, 2025 | -0.8226 |
| August 31, 2025 | -1.027 |
| May 31, 2025 | -0.5182 |
| February 28, 2025 | -0.6744 |
| November 30, 2024 | -0.7467 |
| August 31, 2024 | -0.6727 |
| May 31, 2024 | -0.7141 |
| February 29, 2024 | -0.7562 |
| November 30, 2023 | -0.7674 |
| August 31, 2023 | -0.6799 |
| May 31, 2023 | -0.4474 |
| February 28, 2023 | -0.7539 |
| November 30, 2022 | -0.866 |
| Date | Value |
|---|---|
| August 31, 2022 | -0.8986 |
| May 31, 2022 | -1.011 |
| February 28, 2022 | -0.9516 |
| November 30, 2021 | -0.8462 |
| August 31, 2021 | -0.6498 |
| May 31, 2021 | -0.6023 |
| February 28, 2021 | -0.626 |
| November 30, 2020 | -0.5145 |
| August 31, 2020 | -1.77 |
| May 31, 2020 | 0.1959 |
| February 29, 2020 | -0.957 |
| November 30, 2019 | -0.348 |
| August 31, 2019 | -0.2206 |
| May 31, 2019 | -0.0793 |
| February 28, 2019 | -0.2074 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | -8.444 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
| Savara, Inc. | -0.1587 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -89.54M |
| Revenue (Quarterly) | 9.043M |
| Total Expenses (Quarterly) | 98.58M |
| Enterprise Value | 1.913B |
| Gross Profit Margin (Quarterly) | 57.43% |
| Profit Margin (Quarterly) | -990.1% |
| Earnings Yield | -15.56% |
| Normalized Earnings Yield | -15.56 |